JP2024536868A5 - - Google Patents

Info

Publication number
JP2024536868A5
JP2024536868A5 JP2024518874A JP2024518874A JP2024536868A5 JP 2024536868 A5 JP2024536868 A5 JP 2024536868A5 JP 2024518874 A JP2024518874 A JP 2024518874A JP 2024518874 A JP2024518874 A JP 2024518874A JP 2024536868 A5 JP2024536868 A5 JP 2024536868A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
cycloalkyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518874A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536868A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/076999 external-priority patent/WO2023049885A1/en
Publication of JP2024536868A publication Critical patent/JP2024536868A/ja
Publication of JP2024536868A5 publication Critical patent/JP2024536868A5/ja
Pending legal-status Critical Current

Links

JP2024518874A 2021-09-27 2022-09-26 ベンズイミダゾール及びアザベンズイミダゾールｉｌ－１７阻害剤化合物 Pending JP2024536868A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163248561P 2021-09-27 2021-09-27
US63/248,561 2021-09-27
US202163273395P 2021-10-29 2021-10-29
US63/273,395 2021-10-29
PCT/US2022/076999 WO2023049885A1 (en) 2021-09-27 2022-09-26 Benzimidazole and azabenzimidazole il-17 inhibitor compounds

Publications (2)

Publication Number Publication Date
JP2024536868A JP2024536868A (ja) 2024-10-08
JP2024536868A5 true JP2024536868A5 (cg-RX-API-DMAC7.html) 2025-09-30

Family

ID=83995644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518874A Pending JP2024536868A (ja) 2021-09-27 2022-09-26 ベンズイミダゾール及びアザベンズイミダゾールｉｌ－１７阻害剤化合物

Country Status (5)

Country Link
US (1) US20250122181A1 (cg-RX-API-DMAC7.html)
EP (1) EP4408837A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024536868A (cg-RX-API-DMAC7.html)
CA (1) CA3233622A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023049885A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202430165A (zh) 2022-12-02 2024-08-01 丹麥商理奧藥品公司 Il-17之小分子調節劑
CN120731202A (zh) * 2023-01-30 2025-09-30 戴斯阿尔法公司 基于苯并咪唑和氮杂-苯并咪唑的il-17a调节剂及其用途
CN117567323A (zh) * 2023-10-30 2024-02-20 湖北泰盛化工有限公司 一种(s)-4-氯-2-((甲氧基羰基)氨基)丁酸乙酯的制备方法
WO2025104230A1 (en) * 2023-11-17 2025-05-22 Sanofi Benzoxazoles as modulators of il-17a

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072534A1 (es) 2008-07-25 2010-09-01 Gilead Sciences Inc Compuestos antivirales
US11472794B2 (en) * 2018-01-15 2022-10-18 UCB Biopharma SRL Fused imidazole derivatives as IL-17 modulators
CN113999234B (zh) * 2020-07-28 2023-03-07 成都先导药物开发股份有限公司 一种免疫调节剂

Similar Documents

Publication Publication Date Title
JP2024536868A5 (cg-RX-API-DMAC7.html)
JP2023524018A5 (cg-RX-API-DMAC7.html)
JP2024536869A5 (cg-RX-API-DMAC7.html)
JP2024536863A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2024536862A5 (cg-RX-API-DMAC7.html)
IL311751A (en) IL-17 imidazopyridazine inhibitory compounds
EP2044023B1 (en) Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
JP5845283B2 (ja) インゲノール−３−アシラートｉｉｉおよびインゲノール−３−カルバメート
JP2024546950A5 (cg-RX-API-DMAC7.html)
JP2012521994A5 (cg-RX-API-DMAC7.html)
JP2024546951A5 (cg-RX-API-DMAC7.html)
JP2014037426A5 (cg-RX-API-DMAC7.html)
JP2015501820A5 (cg-RX-API-DMAC7.html)
JP2016147858A5 (cg-RX-API-DMAC7.html)
JP2025509697A5 (cg-RX-API-DMAC7.html)
JP2019531279A5 (cg-RX-API-DMAC7.html)
JP2009537544A5 (cg-RX-API-DMAC7.html)
CA2679198A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
JP2023512664A5 (cg-RX-API-DMAC7.html)
CA2290136A1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
TW201609679A (zh) 磷脂酸肌醇-3-激酶抑制劑的製造方法
JP2020528913A5 (cg-RX-API-DMAC7.html)
JP2022526553A5 (cg-RX-API-DMAC7.html)
JP2018509426A5 (cg-RX-API-DMAC7.html)